在阿尔茨海默病（Alzheimer's disease，AD）的研究领域，一直存在着诸多谜团等待科学家们去解开。淀粉样蛋白 β（Amyloid-beta，Aβ）和 tau 蛋白的沉积，是 AD 的标志性病理特征 ，可这些病理变化往往在临床症状出现前许多年就已悄然开始。如今，针对 AD 的疾病修饰疗法，比如抗 Aβ 和抗 tau 抗体疗法不断涌现，这就使得在疾病的临床前期实现早期检测和精准预测 AD ...

PET-CT imaging with [18 F]fluorodeoxyglucose (FDG) and [18 F]fluorocholine (FCH) altered treatment plans in only a tiny ...

该研究首次证实了 68 Ga-pentixafor PET/MRI技术在库欣病术前定位中的价值，特别是在传统MRI难以检测的患者中，为手术策略优化提供了更精确的依据。

However, this issue has been overcome, and hybrid PET/MRI machines are appearing in hospitals as the most advanced imaging technology. The remaining challenge was the development of a dual-purpose ...

Cubresa’s NuPET™ is a revolutionary in-bore PET scanner that inserts into existing MRI instruments to create a powerful and flexible hybrid preclinical in vivo imaging platform that combines ...

Hepatocellular carcinoma continues to pose a diagnostic challenge, particularly in the setting of underlying pathomorphological changes in the liver due to cirrhosis, steatosis, or steatohepatitis.

The Sheffield PET-MRI facility is the UK’s 8th and Yorkshire’s only PET-MRI facility. It is set in a purpose built state-of-the-art facility that is attached to the existing University of Sheffield ...

Market Growth Is Driven by Technological Innovations and An Increasing Incidence of Chronic Diseases.Pune, Feb. 19, 2025 (GLOBE NEWSWIRE) -- Global Positron Emission Tomography Market Size & Growth ...

Cubresa is pleased to announce that it has signed a global Master Interface Agreement with Siemens Healthineers. The agreement is a broad contract designed to support development efforts and ...